Review article: the clinical pharmacology of proton pump inhibitors

@article{Sachs2006ReviewAT,
  title={Review article: the clinical pharmacology of proton pump inhibitors},
  author={G. Sachs and J. M. Shin and C. Howden},
  journal={Alimentary Pharmacology & Therapeutics},
  year={2006},
  volume={23}
}
Proton pump inhibitors inhibit the gastric H+/K+‐ATPase via covalent binding to cysteine residues of the proton pump. All proton pump inhibitors must undergo acid accumulation in the parietal cell through protonation, followed by activation mediated by a second protonation at the active secretory canaliculus of the parietal cell. 
View on Wiley
onlinelibrary.wiley.com
269 Citations
Highly Influential Citations
12
Background Citations
101
Methods Citations
1
Results Citations
2

Paper Mentions

Interventional Clinical Trial
Oral Omeprazole in Bleeding Peptic Ulcer
Find out if there is a significant difference between clinical outcome among the patients with bleeding peptic ulcer treated with oral omeprazole compared to those treated with… Expand
ConditionsBleeding Peptic Ulcer
InterventionDrug
Assiut University
November 2019 - January 2021

269 Citations

Citation Type

Citation Type

Proton pump inhibitors: actions and reactions.
  • 85
  • Highly Influenced
Proton pump inhibitors are now massively utilized medications worldwide but their H + ,K + -ATPase and non-H + ,K + -ATPase mediated side effects are poorly appreciated
Proton pump inhibitors
  • 120
  • PDF
A REVIEW ON PROTON PUMP INHIBITOR FOR THE TREATMENT OF PEPTIC ULCER
Safety of proton pump inhibitor exposure.
  • 183
Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
  • 22
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z
  • 47
Safe use of proton pump inhibitors in patients with cirrhosis
  • 18
  • PDF
Analysis of Proton Pump Inhibitors in Bulk and In Different Dosage Forms -A Review
  • 2
  • PDF
Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy
  • 109
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Review article: immediate‐release proton‐pump inhibitor therapy – potential advantages
  • C. Howden
  • Chemistry, Medicine
  • Alimentary pharmacology & therapeutics
  • 2005
  • 71
Physiology of the Parietal Cell and Therapeutic Implications
  • G. Sachs
  • Chemistry, Medicine
  • Pharmacotherapy
  • 2003
  • 32
Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
  • 203
Restoration of acid secretion following treatment with proton pump inhibitors.
  • 88
Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half‐life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers
  • 82
Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
  • 51
Improving on PPI-based therapy of GORD.
  • G. Sachs
  • Medicine
  • European journal of gastroenterology & hepatology
  • 2001
  • 43
Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
  • 131
The site of action of pantoprazole in the gastric H+/K(+)-ATPase.
  • 100
Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
  • 48
...
1
2
3
4
...